Fertility and Sterility
Volume 75, Issue 2 , Pages 305-309 , February 2001

Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate

Presented in part at the 56th Annual Meeting of the American Society for Reproductive Medicine, San Diego, California, October 21–26, 2000. Recipient of the Prize Paper of The Society for Reproductive Endocrinology and Infertility.

  • Mohamed F.M Mitwally, M.D.

      Affiliations

    • Division of Reproductive Sciences, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
    • ,
  • Robert F Casper, M.D.

      Affiliations

    • The Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada
    • Corresponding Author InformationReprint requests: Robert F. Casper, M.D., Reproductive Biology Unit, 600 University Avenue, Toronto, Ontario, M5G 1X5, Canada (FAX: 416-586-5033

Received 22 March 2000 ,Revised 16 August 2000 ,Accepted 16 August 2000.

References 

  1. Shoham Z, Weissman A. Polycystic ovarian disease: obesity and insulin resistance. In: Kempers RD, Cohen J, Haney AF, Younger JB, eds. Fertility and reproductive medicine. Amsterdam, New York, Oxford, Shannon, Singapore, Tokyo: Elsevier, 1998:263–72.
  2. Franks S. Polycystic ovary syndrome. N Engl J Med 1995;333:853–61. [Erratum, N Engl J Med 1995;333:1435.]
  3. Franks S, Adams J, Mason H, Polson D. Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynecol. 1985;12:605–632
  4. Hull MGR. The causes of infertility and relative effectiveness of treatment. In:  Templeton AA,  Drife JO editor. Infertility. London: Springer-Verlag; 1992;p. 33–62
  5. Kistner R. Induction of ovulation with clomiphene citrate (Clomid). Obstet Gynecol Surv. 1965;20:873–900
  6. Rabau E, Serr D, Mashiach S, Insler V, Salomy M, Lunenfeld B. Current concepts in the treatment of anovulation. Br Med J. 1967;4:446–449
  7. Mikkelson TJ, Kroboth PD, Cameron WJ, Dittert LW, Chungi V, Manberg PJ. Single-dose pharmacokinetics of clomiphene citrate in normal volunteers. Fertil Steril. 1986;46:392–396
  8. Randall JM, Templeton A. Cervical mucus score and in vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles. Fertil Steril. 1991;56:465–468
  9. Gonen Y, Casper RF. Sonographic determination of an adverse effect of clomiphene citrate on endometrial growth. Hum Reprod. 1990;5:670–674
  10. Gysler M, March C, Mishell DJ, Bailey EJ. A decade’s experience with an individualized clomiphene treatment regimen including its effects on the postcoital test. Fertil Steril. 1982;37:161–167
  11. Hammond M, Halme J, Talbert L. Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation. Obstet Gynecol. 1983;62:196–202
  12. Kettel LM, Roseff SJ, Berga SL, Mortola JF, Yen SSC. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome. Fertil Steril. 1993;59:532–538
  13. Fisch P, Casper RF, Brown SE, Wrixon W, Collins JA, Reid RL, et al.  Unexplained infertility (evaluation of treatment with clomiphene citrate, human chorionic gonadotropin or in vitro fertilization). Fertil Steril. 1989;51:828–833
  14. Lipton A, Demers L, Harvey H, Kambic K, Grossberg H, Brady C, et al.  Letrozole (CGS 20267) (a phase I study of a new potent oral aromatase inhibitor of breast cancer). Cancer. 1995;75:2132–2138
  15. Iveson T, Smith I, Ahern J, Smithers D, Trunet P, Dowsett M. Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in postmenopausal patients with advanced breast cancer. Cancer Res. 1993;53:266–270
  16. Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome (towards a rational approach). In:  Dunaif A,  Givens JR,  Haseltine F,  Merriam GR editor. Polycystic ovary syndrome. Boston: Blackwell; 1992;p. 377–384
  17. Clark JH, Markaverich BM. The agonistic-antagonistic properties of clomiphene (a review). Pharmacol Ther. 1981;15:467–519
  18. Adashi EY. Clomiphene citrate (mechanism(s) and site(s) of action—a hypothesis revisited). Fertil Steril. 1984;42:331–344
  19. Sioufi A, Gauducheau N, Pineau V, Marfil F, Jaouen A, Cardot JM, et al.  Absolute bioavailability of letrozole in healthy post-menopausal women. Biopharm Drug Dispos. 1997;18:779–789
  20. Shetty G, Krishnamurthy H, Krishnamurthy HN, Bhatnagar S, Moudgal RN. Effect of estrogen deprivation on the reproductive physiology of male and female primates. J Steroid Biochem Mol Biol. 1997;61:157–166
  21. Weil SJ, Vendola K, Zhou J, Adesanya OO, Wang J, Okafor J, et al.  Androgen receptor gene expression in the primate ovary (cellular localization, regulation, and functional correlations). J Clin Endocrinol Metab. 1998;83:2479–2485
  22. Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab. 1999;84:2951–2956
  23. Vendola K, Zhou J, Wang J, Famuyiwa OA, Bievre M, Bondy CA. Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol Reprod. 1999;61:353–357
  24. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest. 1998;101:2622–2629
  25. Adashi E. Intraovarian regulation (the proposed role of insulin-like growth factors). Ann N Y Acad Sci. 1993;687:10–12
  26. Giudice LC. Insulin-like growth factors and ovarian follicular development. Endocr Rev. 1992;13:641–669
  27. Yen SSC, Laughlin GA, Morales AJ. Interface between extra- and intra-ovarian factors in polycystic ovary syndrome (PCOS). Ann N Y Acad Sci. 1993;687:98–111
  28. Lobo RA, Paul W, March CM, Granger L, Kletzky OA. Clomiphene and dexamethasone in women unresponsive to clomiphene alone. Obstet Gynecol. 1982;60:497–501
  29. Singh KB, Dunnihoo DR, Mahajan DK, Bairnsfather LE. Clomiphene-dexamethasone treatment of clomiphene resistant women with and without the polycystic ovary syndrome. J Reprod Med. 1992;37:215–218
  30. Daly DC, Walters CA, Soto-Albors CE, Tohan N, Riddick DH. A randomized study of dexamethasone in ovulation induction with clomiphene citrate. Fertil Steril. 1984;41:844–848
  31. Diamant YZ, Evron S. Induction of ovulation by combined clomiphene citrate and dexamethasone treatment in clomiphene citrate nonresponders. Eur J Obstet Gynecol Reprod Biol. 1980;11:335–340
  32. Garcia-Flores RF, Vazquez-Mendez J. Progressive dosages of clomiphene in hypothalamic anovulation. Fertil Steril. 1984;42:543–547
  33. O’Herlihy C, Pepperell RJ, Brown JB, Smith MA, Sandri L, McBain JC. Incremental clomiphene therapy (a new method for treating persistent anovulation). Obstet Gynecol. 1981;58:535–542
  34. Lobo RA, Granger LR, Davajan V, Mishell DR. An extended regimen of clomiphene citrate in women unresponsive to standard therapy. Fertil Steril. 1982;37:762–766
  35. Fluker MR, Wang IY, Rowe TC. An extended 10-day course of clomiphene citrate (CC) in women with CC-resistant ovulatory disorders. Fertil Steril. 1996;66:761–764

☆ Supported by an operating grant from the Medical Research Council of Canada, Ottawa, Ontario, Canada; and an unrestricted grant from Sage Biopharma Inc., Bedminster, New Jersey.

PII: S0015-0282(00)01705-2

Fertility and Sterility
Volume 75, Issue 2 , Pages 305-309 , February 2001

Article Tools